SB196 Alabama 2012 Session

Updated Feb 27, 2026

Notable

Summary

Primary Sponsor: Gerald O. Dial
Republican
Session: Regular Session 2012
Title: Medicaid programs, ensuring appropriate access to medicines for premature infants, created, Medicaid program required to develop and implement policies to streamline process for access to covered drug for premature infants.
Summary: SB196 would require Alabama's Medicaid Agency to create streamlined, 24-hour prior authorization rules and other policies to ensure timely access to covered outpatient medicines for premature infants.
What This Bill Does
The bill creates the Ensuring Appropriate Access to Medicines for Premature Infants Act and requires the Medicaid Agency to develop policies to speed up access to prescribed outpatient drugs for premature infants. It sets a 24-hour deadline for prior authorization decisions, with fast-track processing and notice to providers, and allows denials to be appealed with the possibility of continued coverage during appeals. It also requires electronic/fax/phone submission, public posting of PA requirements, a robust appeals process with consumer protections, dosage consistency with FDA labeling, and annual reporting on health outcomes related to access, applying to all Medicaid programs in the state.

Who It Affects
Premature infants covered by Alabama Medicaid and their families, who would benefit from faster, more reliable access to necessary outpatient medications.
Physicians, nurses, and caregivers who treat premature infants, who gain a clearer, faster, and more transparent prior authorization process, including electronic submission and access to patient information.

Key Provisions
Create the Ensuring Appropriate Access to Medicines for Premature Infants Act and require the Medicaid Agency to develop policies to streamline prior authorization for covered outpatient drugs for premature infants and ensure timely access.
By July 1, 2012, implement policies and procedures to streamline prior authorization and ensure timely access, including fast-track 24-hour decision timelines and clear rationale for approvals/denials.
Require 24-hour decisions for prior authorization with approvals/denials, rationale, and appeals information; provide for fast-tracking seasonal/periodic drugs; attempt provider contact before denial; issue a time-stamped notice of receipt; and deem approvals if not adjudicated within 24 hours.
Allow prior authorization submissions electronically, by fax, or by telephone.
Post all PA requirements, forms, rationale, and appeals processes publicly by drug or therapeutic area on the Medicaid website.
Develop a strong appeals process with protections, including continued coverage during appeals, access to patient files, timely reviews, and Uniform External Review protections.
Ensure all medicines prescribed to premature infants are given at FDA-prescribed dosage and duration.
Monitor and track health outcomes (readmissions, ED visits, outpatient visits) for premature infants denied drugs and report data/findings to the Legislature annually.
Develop standards and common practices for all Medicaid programs to ensure timely access to care for premature infants; policies are binding across programs.
Effective immediately after passage and governor approval.

AI-generated summary using openai/gpt-5-nano on Feb 25, 2026. May contain errors — refer to the official bill text for accuracy.
Subjects: Medicaid Agency